Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Apricot Therapeutics has developed the 4i DRP platform to enable multiplexed, high-resolution spatial analysis of patient biopsies. This allows identification of responders/nonresponders to therapies at the single-cell level. The company has signed multiple academic and industry collaborations—including trials in ovarian cancer—and is building a unique data resource for AI-driven precision medicine.[1][3][5] No direct clinical trial results as it does not develop drugs itself.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Apricot Therapeutics AG.